DTU Logo
Overview | 4-T | ACE | ADOPT | AFORRD | DREAM | EDIT | EXSCEL | FHS | GLINT | ISAT | LDS | NAVIGATOR | TECOS | UKPDS

A Diabetes Outcomes Progression Trial



The study was led by an academic steering committee but run operationally and funded by GlaxoSmithKline. We are grateful to the 4360 participants in 488 North American and European Centres for their help in undertaking this trial.

Study number

ClinicalTrials.gov Identifier: NCT00279045

Steering Committee

S. Kahn, G. Viberti (co-chairs), S. Haffner, W. Herman, R. Holman, N. Jones, J. Lachin, C. O'Neill, and B. Zinman

Data Safety Monitoring Board

A. Garber, M. Fisher (co-chairs), H. Dargie, and J. Fuller

Safety Analysis Group at University of Wisconsin-Madison

E. Roecker, and T. Havighurst

Adjudication Committee

M. Abrahamson (chair), D. Kelley, and J.-F. Yale

ADOPT Study Management Team

A. Phillips, M. Freed, C. O'Neill, B. Kravitz, D. Yu, R. Fowler, K. Saarinen, D. Steele-Norwood, K. Huckel, A. Cobitz, B. Louridas, C. Kirsch, J. Balcarek, and A. Wolstenholme

ADOPT Statistics and Data Management Team

M. Heise, G. Paul, J. Koskinas, A. McClatchy, P. Stober, C. Weikert, D. Wade, and J. Wang

Study Sponsor

GlaxoSmithKline